| Mitsudomi T, Yatabe Y
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |
| Okamoto I
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Takeuchi K, Ito F
EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |
| Choi YJ, Rho JK, Jeon BS, et al.
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Nov 18.
Abstract | Full Citation |
| Okudera K, Takanashi S, Hayashi A, et al.
[A Case of Adenocarcinoma of the Lung with a Long-Term Therapeutic Effect Due to S-1 Administered as the Sixth Regimen.] [JOURNAL ARTICLE]
Gan To Kagaku Ryoho 2009 Nov; 36(11):1889-1891.
Abstract | Full Citation | Find Related Articles |
| Azzoli CG, Baker S, Temin S, et al.
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Seike M
MicroRNA Expression Profiles in Lung Cancer Cooperated with Drug Sensitivity to EGFR Tyrosine Kinase Inhibitor. [Journal Article]
J Nippon Med Sch 2009 Oct; 76(5):275-6.
Abstract | Full Citation |
| Moon DO, Kim MO, Heo MS, et al.
Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells. [Journal Article]
Arch Pharm Res 2009 Oct; 32(10):1351-60.
Abstract | Full Citation |
| Lee CH
This month in APR. [Journal Article]
Arch Pharm Res 2009 Oct; 32(10):1333-4.
Full Citation | Publisher Full Text | Find Related Articles |
| Yoshioka H, Hotta K, Kiura K, et al.
A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Nov 5.
Abstract | Full Citation |
  |
